Deep Track Capital, LP Cytokinetics Inc Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Deep Track Capital, LP holds 3,073,853 shares of CYTK stock, worth $113 Million. This represents 4.32% of its overall portfolio holdings.
Number of Shares
3,073,853
Previous 2,500,000
22.95%
Holding current value
$113 Million
Previous $118 Million
5.05%
% of portfolio
4.32%
Previous 5.18%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$537 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$434 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$365 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$293 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$223 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.45B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...